
Danish pharmaceutical company Novo Nordisk's US branch has ended up in a precarious situation due to serious harassment and gender discrimination allegations, which may turn into an expensive package and damage the firm's reputation.
In New Jersey, plaintiff Julie Ann Krueger Skjolaas recently explained in court that she had experienced harassment and gender-based discrimination from Novo Nordisk and her then-manager.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app